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Abstract
After denervation of adult rat abdominal muscles, the postsynap-
tic apparatus of neuromuscular junctions (NMJs) retains its original
architecture and clustering of acetylcholine receptors (AChRs).
When descending ﬁbers of the spinal cord are surgically diverted
to this muscle by a nerve grafting procedure, supraspinal gluta-
matergic neurons can innervate muscle ﬁbers and restore motor
function; the newly formed NMJs switch from a cholinergic to a
glutamatergic-type synapse. We show here that regenerating nerve
endings contact the ﬁbers in an area occupied by cholinergic
endplates. These NMJs are morphologically indistinguishable from
those in controls, but they differ in the subunit composition of
AChRs. Moreover, by immunoﬂuorescence and immunoelectron
microscopy, new NMJs express glutamatergic synapse markers.
The >-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptor subunit GluR1 partially colocalizes with AChRs,
and vesicular glutamate transporter 2 is localized in the presynaptic
compartment. Immunoprecipitation analysis of membranes from
reinnervated muscle showed that AMPA receptor subunits GluR1
and GluR2 coimmunoprecipitate with rapsyn, the AChR-anchoring
protein at the NMJ. Taken together, these results indicate that cho-
linergic endplates can be targeted by new glutamatergic projections
and that the clustering of AMPA receptors occurs there.
Key Words: Acetylcholine receptors, AMPA receptors, Glutamate,
Neuromuscular junction, Reinnervation, Spinal cord injury, Synap-
tic plasticity.
INTRODUCTION
Bypassing a spinal cord lesion by connecting healthy
descending motor ﬁbers with skeletal muscle may represent
a promising surgical approach for the treatment of para-
plegia (1, 2). We recently demonstrated that axotomized
rat glutamatergic supraspinal neurons can regrow in a pe-
ripheral nerve graft connected to the distal tip of the tran-
sected nerve of abdominal muscles where they target the
muscle ﬁbers and make functional synapses. The glutamater-
gic reinnervation speciﬁes the type of postsynaptic receptor.
Reinnervated muscle ﬁbers express increased amounts of
>-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) glutamate receptor subunits that cluster at the
junctional postsynaptic site. At 2 months after nerve grafting,
nerve-evoked contraction of the skeletal muscles becomes
insensitive to curare but is efﬁciently blocked by the AMPA
receptor antagonist GYKI 52466 (1).
When motor axons regenerate after peripheral nerve
injury, the cholinergic terminals of regrowing motoneurons
reoccupy precisely the original endplate sites (3, 4). When
skeletal muscle is reinnervated by supraspinal glutamatergic
neurons, however, it is not known whether the cholinergic
apparatus is still preserved and whether regenerating gluta-
matergic axons reach the cholinergic endplates rather than
new areas where the postsynaptic glutamatergic receptors are
clustered. The possibility that functional AMPA receptors
assemble at the cholinergic postsynaptic membrane recently
became more plausible when glutamate receptors were
immunolocalized at the neuromuscular junction (NMJ) of
mouse quadriceps (5).
To investigate the presence of cholinergic endplates
and the localization of newly formed glutamatergic synapses
in rat abdominal muscles, we ﬁrst analyzed the structure of
NMJs in the internus obliquus and transversus abdominis
1103J Neuropathol Exp Neurol  Volume 68, Number 10, October 2009
J Neuropathol Exp Neurol
Copyright  2009 by the American Association of Neuropathologists, Inc.
Vol. 68, No. 10
October 2009
pp. 1103Y1115
From the Department of Medical Pharmacology (MF, IC, FC), University of
Milan and CNR Neuroscience Institute, Milan, Italy; Foundation for
Experimental Spinal Cord Research (GB), Neurophysiology of the
Spedali Civili of Brescia (BG), Division of Biology (SB, AB, LLV),
and Pharmacology and Experimental Therapeutics (FB, AL, CB, PS,
MP) of the Department of Biomedical Sciences and Biotechnologies,
School of Medicine, University of Brescia, Brescia, Italy; and Depart-
ment of Neurological and Vision Sciences, Section of Physiology (ME,
MB), University of Verona, Verona, Italy.
Send correspondence and reprint requests to: Maura Francolini, Department
of Medical Pharmacology, University of Milan, via Vanvitelli 32, 20129
Milan, Italy; E-mail: maura.francolini@unimi.it
This work was supported by grants from Ministero dell’Istruzione,
dell’Universita` e della Ricerca, PRIN 2005, 2006, Centro di Studio e
Ricerca sulla Terza Eta`, Brescia; Centro di Eccellenza per la Innovazione
Diagnostica e Terapeutica, University of BresciaYMinistero dell’Istru-
zione, dell’Universita` e della Ricerca; Fondazione Monzino Milano.
Supplemental digital content is available for this article. Direct URL citations
appear in the printed text and are provided in the HTML and PDF
versions of this article on the journal’s Web site (www.jneuropath.com).
Copyright @ 2009 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.
muscles. Both denervated and muscle reinnervated by supra-
spinal neurons after the surgical grafting procedure displayed
stable clusters of acetylcholine receptors (AChRs) at all times
examined. We studied the ultrastructure of the newly formed
neuromuscular synapses and demonstrated by immunoelec-
tron microscopy that the NMJs in muscles surgically
reconnected to the spinal cord by the nerve graft express
markers of glutamatergic synapses. The AMPA receptors
clustered at the postsynaptic membrane and partially coloc-
alize with AChRs by interacting with anchoring proteins of
the cholinergic postsynaptic apparatus.
MATERIALS AND METHODS
Surgical Procedure
All experimental and surgical procedures conformed to
the National Research Council’s Guide for the Care and Use
of Laboratory Animals and were approved by the Animal
Research Committees of the University of Brescia. In male
adult Wistar rats, a laminectomy was performed to expose the
T10YL1 cord segment. The dura mater was opened over
3 mm on the lateral aspect of the cord. Roots were gently
retracted, and an incision 2 mm deep was made in the lateral
funiculus of the right T11YT12 spinal cord with a no. 11
blade. A stump of a peripheral nerve 50 mm long from the
sural nerve of the same animal was inserted 1.5 mm into the
cord incision. The graft was secured by tying a 9Y0 suture
through the epineurium of the peripheral nerve and the dura
mater. The motor nerve innervating the right internal
abdominal oblique and transversus muscles was transected,
and the distal stump (20 mm long) was anastomosed to the
free end of the grafted nerve by an 11Y0 nylon suture.
Postoperative treatment with enroﬂoxacine (10 mg/kg per
day) was carried out for 6 consecutive days.
At different time points (from 2 to 10 months) after
graft implantation into the right lateral funiculus of the spinal
cord, rats were monitored for muscle reinnervation and
function by an electromyographic device (Nicolet Biomed-
ical, Madison, WI). Rats were deeply anesthetized and
mechanically ventilated. Control and reinnervated abdominal
muscles were exposed, and compound muscle action poten-
tials (CMAPs) were measured in response to direct nerve
stimulation. Rats were injected with vecuronium (800 Kg/kg,
intravenously). Nerve stimulation and CMAP recordings in
reinnervated and control muscles were performed 30 minutes
after drug injection, as described (1). In 6 animals, oblique
and transversus abdominis muscles were surgically dener-
vated by resection of their motor nerve.
Immunoﬂuorescence Analysis
Denervated muscles were dissected and observed 10
days and 1 and 2 months after surgery. On a small portion of
the muscle (3 mm  1 cm), AChR clusters were stained by
immersion in a solution of tetramethylrhodamine-conjugated
>-bungarotoxin (TRITC-BuTx; Molecular Probes, Eugene,
OR), 15 Kg/mL in PBS (0.8% NaCl, 0.02% KCl, 0.144%
Na2HPO4, 0.024% KH2PO4), pH 7.4, for 30 minutes, washed
in PBS, and ﬁxed with 4% paraformaldehyde in phosphate
buffer 120 mmol/L, pH 7.4, overnight at 4-C. Fixed muscles
were teased into thin bundles containing 10 to 20 muscle
ﬁbers that were processed for immunoﬂuorescence with
monoclonal antibodies against synaptophysin (1:100, Sigma,
St Louis, MO). Brieﬂy, the bundles were immersed for
2 hours in blocking solution (5% horse serum, 1% bovine
serum albumin, 1% Triton-X100 in PBS, pH 7.4); they were
then incubated with the primary antibodies diluted as
indicated in blocking solution overnight at 4-C, washed in
PBS supplemented with 0.5% Triton-X100, and incubated
with ﬂuorescence labeled secondary antibodies diluted in the
same buffer for 2 hours. After extensive washing, the sam-
ples were mounted on glass slides with Mowiol (Sigma-
Aldrich).
Reinnervated and control muscles were dissected at
different time points after surgery; NMJ-enriched areas were
cut, incubated with TRITC-BuTx, and ﬁxed with 4%
paraformaldehyde. Fixed tissues were further divided into
bundles of 10 to 20 ﬁbers of approximately 5 to 7 mm; the
surgical dissection of these samples from the whole muscle
was done under the stereomicroscope in the area of the
terminal arborization of the grafted nerves and were
processed for immunoﬂuorescence as described with anti-
bodies against the GluR1 subunit of the AMPA glutamate
receptor (1:200; Chemicon, Temecula, CA), the vesicular
glutamate transporter 2 (1:2000; VGLUT2 Synaptic System,
Goettingen, Germany), synaptosome-associated protein of
25 kd (1:100, SNAP-25; Sigma), and synaptobrevin (1:100;
VAMP2 Synaptic Systems). Visualization was performed by
confocal microscopy (BioRad MRC1024, Hempstead, UK)
after labeling with Alexa 488 (1:100; Molecular Probes)- and
Cy5 (1:100; Jackson ImmunoResearch, West Grove, PA)-
conjugated secondary antibodies. The entire surface of the
sample was surveyed and checked for the presence of
positive labeling, and all the confocal images were acquired
using the same settings to evaluate differences in staining
intensities between control and reinnervated NMJs.
Transmission Electron Microscopy and
Immunogold Labeling
For transmission electron microscopy (TEM) analysis,
bundles of ﬁbers from control and reinnervated muscles were
brieﬂy ﬁxed by immersion in 4% paraformaldehyde in
phosphate buffer (30 minutes), washed, and incubated with
TRITC-BuTx, as previously described. Regions of the
sample enriched in NMJs, as identiﬁed with BuTx staining,
were reduced in size to small segments of 4 to 5 ﬁbers of
1-mm length and were entirely examined. These samples
were further ﬁxed with 2% glutaraldehyde in cacodylate
buffer and processed for TEM. Brieﬂy, after ﬁxation, the
samples were postﬁxed with osmium tetroxide, rinsed, en
bloc stained with 1% uranyl acetate in water, dehydrated,
and embedded in epoxy resin (Epon 812; Electron Micro-
scopy Science, Hatﬁeld, PA); blocks were baked for
24 hours at 67-C. Rat hippocampus, used for the immu-
nogold experiments, was ﬁxed by immersion in 2% gluta-
raldehyde in cacodylate buffer and processed as described.
Thin sections were obtained with an ultramicrotome (Reichert
Ultracut E; Leica Microsystems, Vienna, Austria), stained
with uranyl acetate and lead citrate, and examined with a
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Philips CM10 TEM. For immunolabeling experiments, we
applied the method described by Phend and colleagues (6) to
tissue sections ﬁxed in 2% glutaraldehyde and embedded in
Epon epoxy resin, as previously indicated. Fixation with
high-concentration glutaraldehyde and epoxy resin embed-
ding have been reported to retain tissue glutamate and make
it available for subsequent immunolocalization at the TEM
level (7). Freshly cut thin sections of rat hippocampus and
control and reinnervated muscles were collected on nickel
grids, washed in Tris-buffered saline with Triton ([TBST]
0.05 mol/L Tris, pH 7.6, 0.9% NaCl, 0.1% Triton-X100) for
5 minutes and then incubated with an antiserum against
glutamate (1:50,000; Sigma) in TBST overnight in a moist
chamber. After extensive rinsing with TBST, pH 7.6, the grids
are ﬂoated on top of drops of TBST, pH 8.2, and subsequently
incubated with a secondary antibody conjugated to 12-nm
gold particles diluted in TBST, pH 8.2 (1:50, Jackson
ImmunoResearch), for 1 hour at room temperature (RT). The
speciﬁcity of the rabbit antiserum against glutamate has
been characterized and previously described (8, 9). According
to the manufacturer’s speciﬁcations, the antiglutamate anti-
serum does not cross-react with L-aspartate, L-glutamine, L-
asparagine, and L-alanine but may cross-react with dipeptides
containing glutamate in a carboxy-terminal position (i.e. Asp-
Glu and Gly-Glu); however, the high working dilution of the
antiserum (1:50,000) strongly suggests that it has high afﬁnity
and speciﬁcity for glutamate in our immunolabeling experi-
ments. Immunostaining speciﬁcity was further evaluated by
omitting the primary antiserum, by incubating the grids with
nonimmune rabbit serum (1:50,000 in TBST, pH 8.2), and by
preabsorption experiments in which the primary antiserum was
exposed to an excess of antigen (10 mmol/L glutamate, for 5
hours at RT) (6) (Figure, Supplemental Digital Content 3,
http://links.lww.com/NEN/A59).
TABLE 1. Distribution of Glutamate Immunoreactivity in Presynaptic Terminals of Central Synapses, Reinnervated, and Control
NMJs Junctions
Compartments Observed Gold, ng Observed Points (P) LD Values (ng/P ap) Expected Gold, ne RLI Values W
2 Values
Reinnervated NMJs
Vesicles 116 805 14.41 65.11 1.78 39.77*
Axoplasm 139 2623 5.29 212.16 0.65 25.22†
Mitochondria 117 1171 9.99 94.71 1.23 5.24
Total 372 4599 8.08 372 1 70.23‡
Control NMJs
Vesicles 15 527 2.84 21.07 0.72 1.74
Axoplasm 71 1952 3.63 78.05 0.91 0.63
Mitochondria 47 847 5.54 33.86 1.38 5.09
Total 133 3326 3.99 133 1 13.46
Hippocampal synapses
Vesicles 1247 1273 97.9 983.62 1.26 70.52*
Axoplasm 184 586 31.34 452.79 0.4 159.56†
Mitochondria 68 81 8.39 62.58 1.08 0.469
Total 1499 1940 77.26 1499 1 230.549‡
A test for randomness was applied to vesicles, mitochondria, and axoplasm of reinnervated and control neuromuscular junctions (NMJs) and central excitatory synapses (Materials
and Methods). The subcompartment surface areas were estimated stereologically by random superimposition of a 0.01 Km2 square grid (ap = 0.01 Km
2) on the micrographs and
counting the number of intersections between the grid lines and each subcompartment. Labeling densities and relative labeling index were then estimated for every compartment, and
the results were tested for randomness.
*Number of gold particles signiﬁcantly higher than the expected value (p G 0.001).
†Number of gold particles signiﬁcantly lower than the expected value (p G 0.001).
‡Distribution of gold particles signiﬁcantly deviates from random (p G 0.001).
TABLE 2. Primer Sequences Used for Semiquantitative PCR Analysis
Gene Primer Sequence Tm, -C
AChR>1 >1-F CAC CTA CCA CTT CGT CAT GCA G 60
>1-R ATA AAA ACC TTC CGC ACC CAC T
AChRF F-F CAG CAA GTA CCT GAC CTT CCT CA 60
F-R CCT AAA GAG GAG TTC GCT TCG AG
AChR? ?-F GAA GAG CTG AGC CTG TAT CAC CA 60
?-R TGC CCA TCA ATA TTG TTT TCC AG
A-actin Act-F AAA TCG TGC GTG ACA TTA AAG AG 60
Act-R GAG GGG CCG GAC TCA TCG TAC
AChR>, AChRF, and AChR?, acetylcholine receptor >, F, and ? subunits; Tm, melt temperature.
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Image and Statistical Analysis
Gold particle densities were estimated by measuring
the surfaces of presynaptic proﬁles (total surface of the
bouton excluding the surfaces occupied by mitochondria)
using National Institutes of Health Image software on TEM
micrographs at a ﬁnal magniﬁcation of 36,750. We then
manually counted the gold particles on these surfaces (gold
particles lying on mitochondria were excluded), and the
ratios between gold particle number and surface provided the
density of gold particles expressed as number per square
micrometer (7, 10). Statistical analysis of the density of
glutamate-like immunoreactivity was evaluated with PRISM
software using a 2-tailed unpaired t-test. The immunoelectron
microscopy data were also analyzed with a test for random-
ness (11) to estimate the relationship between glutamate-like
immunoreactivity and synaptic vesicle density in control and
grafted NMJs and hippocampal synapses. To assess the
degree of localization of glutamate, we deﬁned 3 subcom-
partments of each presynaptic terminal: the pool of synaptic
vesicles, the mitochondria, and the axoplasm. The basis of
this statistical evaluation is to compare the expected
distribution in each compartment according to a Brandom
labeling[ with the actual (observed) distribution of gold
particles (11). Gold particles lying in each compartment
(observed gold [ng]) were counted, a test grid lattice of 0.01
Km2 (ap) was applied onto the images, and each intersection
of the grid to a speciﬁc subcompartment was determined to
measure the compartment size (observed points [P]). The
ratio ng/P ap represents the labeling density (LD) of each
compartment (gold particles per square micrometer). From
the observed points of each individual compartment (P) and
the ratio total ng/total P, the expected gold particle density
(ne = [P total ng/total P]) that indicates the distribution
expected if there were random or nonspeciﬁc labeling. For
every compartment, the ratio ng/ne represented the relative
labeling index (RLI).
The W2 values, calculated from the difference between
observed and expected gold particles in each subcompart-
ment (ng-ne)2/ne, were used to assess statistical signiﬁcance
of the distribution of gold particles in the 3 subcompartments
deﬁned (Table 1).
Reverse TranscriptionYPolymerase Chain
Reaction Analysis
Total RNA extracted from muscle specimens from
regions enriched with nerve branches was analyzed by
reverse transcriptionYpolymerase chain reaction (RT-PCR)
to identify the mRNA transcripts for AChR subunits. Differ-
ent sets of primer pairs were used together with primers for
A-actin, which was used as an internal standard (Table 2). An
Agilent 2100 bioanalyzer was used for semiquantitative RT-
PCR analysis (12).
Western Blot Analysis and
Coimmunoprecipitation
Total protein extracts from portions of muscles that had
received nerve branches were processed for Western blot
analysis with antibodies against GluR1 (1:100; Chemicon),
GluR2 (1:200; Chemicon); synapse-associated protein 97
([SAP97] 1:1000; Afﬁnity BioReagent, Inc, Golden, CO),
glutamate transporter 1 (GLT1) (0.5 Kg/mL), and glutamate
aspartate transporter (GLAST) (0.5 Kg/mL) gift of Dr Grazia
Pietrini from the University of Milan, Italy (13), and AIII
tubulin antibody (1:1500; Promega, Madison, WI). Homog-
enization was carried out by 10 strokes in a Teﬂon-glass
homogenizer (700 rpm) in 4 mL/g of cold 0.32 mol/L sucrose
containing 1 mmol/L HEPES, 1 mmol/L MgCl2, 1 mmol/L
NaHCO3, and 0.1 mmol/L phenylmethylsulfonyl ﬂuoride
(pH 7.4) in the presence of a complete set of protease in-
hibitors (Complete; Boehringer Mannheim, Mannheim, Ger-
many) and phosphatase inhibitors. The homogenized tissue
was centrifuged at 1,000  g for 10 minutes. The resulting
supernatant was centrifuged at 13,000  g for 15 minutes to
obtain a crude membrane fraction. The pellet was resuspen-
ded in 500 KL of buffer containing 1% digitonin, 50 mmol/L
NaCl, 30 mmol/L triethanolamine, pH 7.5, 5 mmol/L EGTA,
FIGURE 1. (A) Analysis of neuromuscular junctions (NMJs) in control, denervated, and reinnervated muscle. The >-bungarotoxin
(BuTx)Ystained NMJs were observed by confocal microscopy; NMJ of control (BuTx Ctrl) rat abdominal muscles with its pretzel-like
appearance and strong ﬂuorescence staining of the TRITC-BuTx bound nicotinic acetylcholine receptors (AChRs). The general
appearance of the NMJs is preserved 2 months after denervation (BuTx D2) and in the reinnervated muscle 2 months after the
grafting procedures (BuTx R2). In reinnervated NMJs, the presynaptic terminals are again present as shown by the staining with a
presynaptic marker VAMP2 (VAMP2 R2). Scale bars = 20 Km. (B) Reverse transcriptionYpolymerase chain reaction analyses of
AChR->1, AChR-?, and AChR-F in control and reinnervated oblique muscles. The data were obtained by coampliﬁcation of A-actin
and the different AChR transcripts in control (C) and reinnervated muscle 2 months (R2) or 10 months (R10) after nerve grafting.
Data are mean T SE of 3 rats per group examined in duplicate. (C) The RT-PCR analyses of AChR->1, AChR-?, and AChR-F in
control and denervated oblique muscles. An example electropherogram on the left traces A-Actin/AchR->1 coampliﬁcation. Upper
and lower markers are used as internal standards to eliminate sample-to-sample variation and to calculate size and concentration
of each PCR product. The data were obtained by coampliﬁcation of A-actin and the different AChR transcripts in control (C) and
denervated muscles at 2 months (D2). Histograms report the AChR/A-Actin ratio. Data are means T SE of 2 rats examined in
triplicate. Data were analyzed by Kruskal-Wallis nonparametric analysis of variance with adjustment for multiple comparisons.
Value p G 0.05 was designated as signiﬁcant. (D) Transmission electron microscopy shows that presynaptic terminals of control
NMJs are ﬁlled with synaptic vesicles and mitochondria. They lay in deep primary folds on the muscle ﬁbers and are covered by
Schwann cells processes. The membrane of the muscle ﬁber is organized into secondary folds; a dense basal membrane occupies
the synaptic cleft (Ctrl). In the grafted muscle, 2 months after surgery (R2, left), reinnervation is occurring and many ﬁbers having
completed the process with a normal appearance of presynaptic terminals; other ﬁbers are still denervated as demonstrated by a
lack of presynaptic nerve endings (arrows in R2, right). Scale bars = 500 nm.
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5 mmol/L EDTA, 50 mmol/L NaF, 2 mmol/L Na orthova-
nadate, 10 mmol/L p-nitrophenylphosphate, 50 Kmol/L
phenylarsine-oxide, 1 mmol/L benzamidine, 1 mmol/L N-
ethylmaleimide, 1 mmol/L Na-tetrathionate, 1 mmol/L
phenylmethylsulfonyl ﬂuoride, 25 Kg/mL aprotinin, and
25 Hg/mL leupeptin, for 30 minutes on ice. To immunopre-
cipitate glutamate receptors, membrane proteins from muscle
homogenates (20Y30 Kg) were incubated overnight at 4-C in
modiﬁed radioimmunoprecipitation assay buffer (10 mmol/L
tris-HCl, pH 8, 140 mmol/L NaCl, 0.5% [vol/vol] Nonidet
P-40, 1 mmol/L sodium orthovanadate, 0.1% sodium dodecyl
sulfate, 1 mmol/L phenylmethylsulfonyl ﬂuoride, 1% pro-
tease inhibitor cocktail) with rabbit polyclonal antibodies
against GluR1 (1:100; Chemicon) and GluR2 (1:200;
Chemicon) or monoclonal anti-GluR1 (1:500 Santa Cruz
Biotechnology, Santa Cruz CA) and anti-GluR2 (Chemicon).
Normal rabbit IgG (Chemicon) was used as control anti-
serum. Protein A/G agarose beads were added, and samples
were rotated for 2 hours at 4-C. The beads were washed,
added to sodium dodecyl sulfateYpolyacrylamide gel electro-
phoresis buffer, and boiled for 2 minutes. After centrifuga-
tion, supernatants were immunoblotted using the following
antibodies: monoclonal anti-rapsyn (1:2000; Afﬁnity Bio-
Reagents), anti-SAP97 (1:1000), anti-PSD95 (1:1000; Afﬁn-
ity BioReagents), and rabbit polyclonal anti-stargazin
(1:1000; Upstate Biotechnology, Lake Placid, NY).
FIGURE 3. Localization of vesicular glutamate transporter 2 (VGLUT2) in neuromuscular junctions (NMJs) of reinnervated muscle.
Control and reinnervated muscle were immunolabeled with antibodies against VGLUT2 at 2 months after surgery. In the NMJs of
the control side (BuTx Ctrl), the signal for VGLUT2 is very faint (VGLUT2 Ctrl) (n = 91). In 33% of the NMJs of the reinnervated
muscle (VGLUT2 R), labeling of the transporter is much higher and it colocalizes with BuTx (BuTx R) (n = 88). The lower panels
show that in reinnervated NMJ, the presynaptic marker SNAP-25, visualized with a Cy5-conjugated secondary antibody (SNAP-25 R),
colocalizes with VGLUT2 (VGLUT2 R) and with the postsynaptic marker BuTx (BuTx R). Scale bars = 20 Km
FIGURE 2. Glutamatergic markers in control and reinnervated neuromuscular junctions (NMJ). Control and reinnervated muscle
samples were processed for immunoﬂuorescence with antibodies against the glutamate receptor 1 (GluR1) subunit of the >-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor; acetylcholine receptors (AChRs) were stained
with >-bungarotoxin (BuTx). (A) The GluR1 is undetectable in control muscle (GluR1 Ctrl); BuTx ﬂuorescence is very bright (BuTx
Ctrl) (n = 168). (B) There is very clear labeling of GluR1 as well as the bright signal from BuTx (BuTx R2, GluR1 R2) in the
reinnervated side 2 months after grafting; this was seen in about 10% of ﬁbers. The ﬂuorescent signals only partially overlap
(merge), that is, a fraction of glutamate receptors are not associated with the AChR clusters. Reinnervation is conﬁrmed by positive
staining for VAMP (VAMP2 R2) (n = 167). (C) At 10 months after surgery, there is staining for GluR1 (GluR1 R10) and for AChRs
(BuTx R10). Scale bars = 20 Km. (D)Western blot analysis (WB) of total extracts from control (C) and reinnervated (R) muscle with
antibodies directed against GluR1, GluR2, synapse-associated protein 97 (SAP97), glutamate aspartate transporter (GLAST), and
glutamate transporter 1 (GLT1). Membranes reprobed with antibodies against AIII-tubulin showed equal amounts of nerve
terminals. No GluR1 was detected in 2 months’ denervated (D) muscle. (E) Coimmunoprecipitation analysis of proteins
interacting with GluR1 and GluR2 subunits in membrane extracts from control (C) and reinnervated (R) muscles. Extracts from
membrane preparation were immunoprecipitated using anti-GluR1 or anti-GluR2 antibody. Precipitates were analyzed by
immunoblotting using antibodies against SAP97, rapsyn, stargazing, and postsynaptic density 95 (PSD-95). A nonrelated
antibody of the same isotype of antibody used for immunoprecipitation (IgG) did not immunoprecipitate SAP97 or rapsyn (lower
panel), stargazin, or PSD-95 (data not shown). All biochemical assays were performed on extracts from 3 animals per experimental
group; each experiment was repeated 3 times.
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RESULTS
Persistence of AChR Clusters in Long-Term
Denervated Muscle Fibers and in Muscle
Reinnervated by the Nerve Grafting Procedure
Six rats were subjected to unilateral denervation of
abdominal muscles; 21 rats were subjected to nerve-grafting
procedures producing muscle reinnervation by supraspinal
neurons, as previously described (1). The CMAP recording of
muscle activity was performed in 16 rats, survived to the
surgery, and reinnervated muscles were selected on the basis
of their insensitivity to vecuronium. In 50% of the recorded
muscles (i.e. in 8 rats), evoked CMAPs were sensitive to cu-
rare administration, indicating that muscles could undergo re-
innervation by cholinergic sprouting either from the spinal
cord or from collateral branching of adjacent, unaffected, cho-
linergic nerves; tissues from these animals were not consid-
ered in this study. Of the registered grafted muscles, 8 were
considered as reinnervated by a noncholinergic innervation be-
cause they were resistant to vecuronium treatment (Figure, Sup-
plemental Digital Content 1, http://links.lww.com/NEN/A57);
these muscle ﬁbers, hereafter referred to as reinnervated ﬁbers,
were dissected for further analysis.
Rat internal oblique and transversus muscles consist of
a broad ﬂat trapezoid abdominal muscle of about 2  3 cm.
Nerve ﬁbers innervating this muscle have broad terminal
arborizations, and the NMJs are diffusely spread over the
entire inner surface of the muscle where they form loose
clusters. Tissue sampling was always from the area of ter-
minal arborization of the grafted nerve into the muscle.
At 10 days or 1 and 2 months after denervation or 2
months after the grafting procedure, dissected muscle ﬁbers
were incubated with TRITC-BuTx to determine whether
AChRs were still clustered in the postsynaptic membrane
(Fig. 1A). In control muscle ﬁbers, the NMJ showed a typical
pretzel-like appearance and strong ﬂuorescence staining of the
AChRs bound by TRITC-BuTx. At 10 days and 1 (not shown)
and 2 months after denervation, the general appearances of
the NMJs were preserved, whereas the muscle itself underwent
progressive atrophy. Lack of labeling with presynaptic
markers conﬁrmed the absence of nerve endings (not shown),
thus conﬁrming the effective denervation of the ﬁbers. By
ﬂuorescence, the AChRs labeled with TRITC-BuTx were still
present in the NMJs in the reinnervated muscles, and their
organization was similar in size and shape to those in the control
ﬁbers. Reinnervation was conﬁrmed by positive staining for
presynaptic markers (VAMP2; Fig. 1A and Figure, Supple-
mental Digital Content 2, http://links.lww.com/NEN/A58,
upper panel). By 2 months after nerve graft implantation, the
reinnervated muscle recovered from atrophy.
Molecular Changes of Nicotinic Receptors in
Reinnervated Motor Endplates
We then analyzed the expression of mRNAs that code
for the nicotinic AChR subunits AChR>1, AChR?, and
AChRF (Fig. 1B). All the AChR mRNAs were expressed in
both control and reinnervated muscles. No signiﬁcant
variation in expression level of AChR>1 and AChR? (which
are contained in adult nicotinic AChRs) was evident in
reinnervated muscles at 2 and 10 months after the grafting
procedure. Conversely, the level of AChRF mRNA (which is
highly expressed in fetal motor endplates and during the early
phase of muscle denervation) seemed stably increased in
reinnervated muscle up to 10 months after the surgery. In
corresponding 2-month denervated ﬁbers, the levels of
AChR>1, AChRF, and AChR? mRNAs were comparable
to those of control muscle (Fig. 1C).
Ultrastructural Analysis of Reinnervated NMJs
Presynaptic terminals in control NMJs laid in deep
primary folds on the muscle ﬁbers and were covered by
Schwann cell processes (Fig. 1D, left panel). The membrane
of the muscle ﬁber was organized into secondary folds, and a
dense basal membrane occupied the synaptic cleft. In long-
term denervated NMJs, the presynaptic nerve terminals were
missing; the primary folds were ﬂattened, whereas the
architecture of the secondary folds was maintained. Muscles
with progressive atrophy accumulated connective tissue
heavily (not shown). At 2 months after nerve grafting, most
of the endplates were still denervated, as demonstrated by a
lack of presynaptic terminals and by ﬂattening of the primary
folds; the secondary folds were preserved (Fig. 1D, right
FIGURE 4. Ultrastructural immunolocalization of glutamate in control and reinnervated neuromuscular junctions (NMJs) and
hippocampus. Thin sections of ﬁbers from control and reinnervated abdominal muscles were immunolabeled with an antibody
against glutamate and then visualized by electron microscopy (EM) with a secondary antibody conjugated to 12 nm gold
particles. In control muscle (A), the NMJ shows only faint labeling; NMJs of the reinnervated muscle (B) show a higher number of
gold particles in every presynaptic proﬁle examined; these gold particles are closely associated with synaptic vesicles (arrows and
inset). (C) Sections of rat hippocampus were similarly immunolabeled with the antiglutamate antibody and visualized by EM; the
glutamatergic synapse is strongly labeled, and gold particles are in close association with synaptic vesicles (inset). Scale bars = 250
nm. (D) Test for randomness was applied to evaluate the distribution of glutamate in hippocampal synapses (n = 15), control
(n = 18), and reinnervated NMJs (n = 16). The labeling densities (Table 1) and relative labeling index (RLI) were estimated for
each compartment, and the results were tested for randomness (W2 analysis). The histogram of the RLI of the 3 subcompartments
(vesicles, axoplasm, mitochondria) that constitute the presynaptic terminals of control and reinnervated NMJs and of
hippocampal synapses shows that the RLI of the vesicles pool in reinnervated NMJs and hippocampal synapses are similar and
differ signiﬁcantly from random distribution (RLI 9 1; p G 0.001), indicating that this compartment is preferentially labeled. By
contrast, the RLI of the soluble component (axoplasm) in both cases is lower than 1 (p G 0.001), indicating that glutamate is not
present in this compartment. The mitochondrial pool RLI is higher than 1 (Table 1) in reinnervated and control NMJs (RLI, 1.23
and 1.38, respectively) and in hippocampal synapses (RLI, 1.08); this could be the results of the localization of metabolic
glutamate inside these organelles and/or the result of the interaction of the antibody with some Krebs cycle intermediates
(i.e. succinate) (6).
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panel). In reinnervated muscles, however, the presynaptic
terminals had a normal phenotype and the postsynaptic
apparatus recovered its original architecture (Fig. 1D, center
panel). At 10 months after surgery, the NMJs showed an
increase in the percentage of reinnervating ﬁbers, and the
presynaptic terminals and postsynaptic specializations were
identical to those of control NMJs (not shown). Ultrastruc-
tural analysis of reinnervated muscles did not show presy-
naptic terminals that contacted the surface of the muscle
ﬁbers in the absence of the postsynaptic specializations typ-
ical of cholinergic endplates.
Newly Formed NMJs Exhibit Markers of
Glutamatergic Synapses
Because after the grafting procedure the abdominal
muscles undergo a functional glutamatergic reinnervation (1),
we analyzed expression of the characteristic proteins of
central glutamatergic synapses by the NMJs in control
(contralateral) and reinnervated tissues from 7 animals by
immunoﬂuorescence. Figure 2A shows the staining pattern of
an NMJ in control muscle. The GluR1 is undetectable,
whereas the BuTx ﬂuorescence of the AChRs is present and
well deﬁned (control NMJs examined, n = 168). On the
grafted side 2 months after surgery, approximately 10% of
the muscle ﬁbers displayed clear labeling of GluR1 in
combination that partially overlapped with the signal
obtained from BuTx (Fig. 2B) (reinnervated NMJs examined,
n = 167). These NMJs were effectively reinnervated as de-
monstrated by staining with a presynaptic marker (VAMP2);
in no cases were there clusters of GluR1 immuno-
reactivity that were not associated with BuTx. Similar results
were obtained in muscle examined at 10 months after the
surgery (Fig. 2C). The positive labeling for GluR1 was
absent in NMJs of muscles that underwent reinnervation by
cholinergic input (Figure, Supplemental Digital Content 2,
http://links.lww.com/NEN/A58, lower panel), as demonstra-
ted by the sensitivity of muscle contraction to vecuronium
administration.
Vecuronium-insensitive and control muscles were im-
munolabeled with antibodies against the VGLUT2 (Fig. 3).
In the NMJs of the control side, the signal for the transporter
was very faint (control NMJs examined, n = 91), whereas in
33% of the NMJs of the reinnervated muscles, the labeling
for the transporter was much higher and aligned with the
proﬁle of the postsynaptic apparatus (reinnervated NMJs
examined, n = 88). Moreover, in reinnervated NMJs, the
staining for VGLUT2 colocalized with the ubiquitous
presynaptic marker SNAP-25; both signals overlapped the
staining of AChRs in the postsynaptic membrane. These data
indicate that new GluR1 subunits accumulate at the post-
synaptic specialization of muscle reinnervated by glutama-
tergic axons and that these proteins are stably inserted in the
clusters of AChRs or in close proximity to them.
To verify interactions of GluRs with anchoring mole-
cules at the cholinergic postsynaptic apparatus or scaffolding
proteins critical at synapses in the central nervous system but
also localized at the skeletal NMJ (14), we performed
immunoblot analysis on muscle total extracts (Fig. 2D) and
membrane preparations (Fig. 2E) of control, denervated, and
reinnervated muscle. Both GluR1 and GluR2 were detected
(albeit at very low levels) in control muscles enriched with
AIII tubulin-positive nerve terminals. As previously shown
(1), the levels of GluR1 and GluR2 subunits increased in total
tissue extracts of reinnervated muscle. No GluR1 protein was
found in corresponding 2-month denervated muscle. Con-
sistent with previous immunolocalization of GLT1 and
GLAST at postsynaptic membrane of rat NMJs (15), we
detected GLT1 and GLAST proteins in tissue extracts with
no apparent difference between control and reinnervated
muscles. Moreover, tissue extracts were positive for SAP97,
a member of the membrane-associated guanylate kinases that
have a key role in the cerebral regulation of AMPA receptor
trafﬁcking and are expressed in NMJs (5, 14). The content of
SAP97 was reduced in reinnervated muscle (Fig. 2D).
Coimmunoprecipitation analysis of proteins interacting with
GluR1 and GluR2 was then performed in membrane
preparations (Fig. 2E). In reinnervated muscle, antibodies to
both GluR1 and GluR2 highly coimmunoprecipitated rapsyn,
the muscle protein anchoring AChRs at the postsynaptic
membrane and which is essential for its clustering at NMJs
(16). Likewise, rapsyn and stargazin, the AMPA recep-
torYinteracting protein at brain postsynaptic densities (17),
coprecipitated with GluR1 and to a lesser extent with the
GluR2 subunit in reinnervated muscle. In addition, large
amounts of SAP97, but not PSD-95, were detected in GluR
immunoprecipitates. None of those proteins was present in
immunoprecipitates performed with unrelated antibodies
(Fig. 2E).
Glutamate-Like Immunoreactivity in
Reinnervated NMJs
Thin sections of rat hippocampus and control and
reinnervated muscles from 3 animals were immunolabeled
with an antibody against glutamate and then visualized at the
TEM level with a secondary antibody conjugated to 12-nm
gold particles. There was only slight labeling in a typical
control NMJ (Fig. 4A and inset), whereas NMJs of the
reinnervated muscle showed more numerous gold particles in
every presynaptic proﬁle examined (Fig. 4B); the particles
were closely associated with synaptic vesicles (Fig. 4B inset).
Sections of rat hippocampus were used as a positive control
for the labeling (Fig. 4C); in these sections, glutamatergic
presynaptic terminals were labeled by the antiglutamate
antibody, and the gold particles were observed in close
association with synaptic vesicles (Fig. 4C inset). Gold
particle densities were determined in presynaptic terminals
of control NMJs (2.9 T 0.45 particles/Km2, n = 18),
reinnervated NMJs (6.72 T 0.70 particles/Km2, n = 16), and
hippocampal synapses (75.1 T 7.82 particles/Km2, n = 15).
Gold particle densities between NMJs of control and
reinnervated muscle were signiﬁcantly different (unpaired
t-test, p e 0.001). We then tested the distribution of glutamate
immunoreactivity by evaluating the RLI of each of 3
subcompartments of the presynaptic terminals of central
excitatory synapses, control and reinnervated NMJs. We
deﬁned the subcompartments as 1) synaptic vesicle pool, 2)
mitochondrial pool, and 3) axoplasm. For each subcompart-
ment, we calculated the labeling density and compared the
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RLI (ratio between the number of observed gold particles and
the expected number according to a random distribution)
(Table 1). This test clearly shows that in reinnervated NMJs
as well as in hippocampal excitatory synapses, the RLI of the
synaptic vesicle compartment was signiﬁcantly higher than
expected according to a random distribution (W2 = 39.77 and
72.61, respectively; p e 0.001), whereas the axoplasm com-
partment RLI was lower (W2 = 25.22 and 158.25, respectively;
p e 0.001). In control cholinergic NMJs, the RLI of each
compartment examined do not signiﬁcantly deviate from
random distribution (Table 1; Fig. 4D). All immunolocaliza-
tion data derived from 3 independent experiments in which
freshly cut thin sections of 2 blocks of hippocampus and at
least 10 different resin blocks each for control and reinner-
vated muscle were processed. Because the NMJs of abdominal
muscle are dispersed in loose clusters, every block of muscle
tissue (4Y5 ﬁbers, 1 mm in length) contains at most 1 or 2; in
reinnervated muscle, some of them might have still been
denervated and thus not usable for this analysis.
DISCUSSION
Connecting the distal stump of the transected nerve of
abdominal muscles with the lateral bundle of rat spinal cord
by a peripheral nerve graft results in functional muscle
reinnervation (1). Reinnervation occurs by axonal elongation
of glutamatergic supraspinal neurons originating from rubro-
spinal, reticulospinal, and vestibulospinal tracts (1). Reinner-
vated muscle becomes insensitive to classical nicotinic
receptor antagonists but sensitive to selective blockers of
glutamate AMPA receptor subtypes (1, 2). The present re-
sults expand on previous evidence showing that by switching
from the cholinergic to the glutamatergic input, the post-
synaptic cholinergic apparatus does not disappear and new
clusters of AMPA receptors colocalize with AChRs.
Acetylcholine is the neurotransmitter operating at the
mammalian NMJ, but glutamate may participate in modulat-
ing cholinergic transmission. This is suggested by the ﬁnding
that presynaptic terminals of rodent NMJs are positive for
glutamate labeling (10, 18). Glutamate release contributes to
the maintenance of the resting membrane potential (19) and
inhibits the nonquantal release of ACh from nerve terminals
(20). Released glutamate would exert its effects through the
activation of postsynaptic N-methyl-d-aspartic acid receptors,
mainly in Type II muscle ﬁbers (21, 22), via nitric oxide
regulation of the chloride transporter (23) or alternatively
through interaction with metabotropic glutamate receptors,
as described for frog NMJs (24). Recently, the presence of
the NR1 and NR2 subunits has been reported along with the
subunits GluR1 and GluR2/3 of the AMPA receptor subtype
in quadriceps muscles of young mice (5). The precise lo-
calization of glutamate in presynaptic terminals remains
elusive, however, since to date, even immunogold experi-
ments failed to demonstrate its association with synaptic
vesicles (10). Data supporting the presence of vesicular
glutamate transporters at NMJs are rather scant. Rat spinal
motoneurons express VGLUT1 and VGLUT2, but these
proteins are conﬁned at terminals contacting Renshaw
inhibitory interneurons and are not present at neuromuscular
synapses (25). The VGLUT1-positive NMJs are found in
striated esophageal muscle but not in other mouse muscle
types (26), and all muscle types were negative for VGLUT2
and 3 immunoreactivity. Although VGLUT3-like immuno-
reactivity in close proximity to the NMJs of rat muscle tissue
was reported (27), recent electrophysiological experiments
failed to demonstrate the contribution of glutamate in neuro-
transmission at mammalian NMJs (28).
Immunoﬂuorescence experiments in the present study
conﬁrmed that connecting the distal stump of abdominal
muscles nerve with the lateral bundle of rat spinal cord
produces a glutamatergic re-innervation of abdominal
muscles. Grafted nerve terminals expressed high levels of
VGLUT1 and VGLUT2 as previously demonstrated by
Western blot analysis of nerve-muscle templates (1). Approx-
imately 30% of the presynaptic terminals of NMJs in re-
innervated muscles were strongly labeled with antibodies
against VGLUT2. This staining colocalizes with other
ubiquitous presynaptic markers, thus indicating that nerve
terminals have the machinery to load glutamate into synaptic
vesicles. Immunogold experiments at the TEM level provided
corroborating evidence that in the presynaptic terminals of
re-innervated NMJs, the glutamate content is signiﬁcantly
higher than in control NMJs. Stereological analysis demon-
strated that glutamate is not dispersed in the axoplasm, but is
associated with the synaptic vesicle pool. The density of
glutamate labeling in presynaptic vesicles of reinnervated
NMJ seemed lower than that observed in control hippo-
campal sections. This might be a consequence of a lower
concentration of glutamate at the presynaptic terminals of
regenerating supraspinal neurons or may have been the result
of the glutamate release from presynaptic terminals in
response to repeated nerve stimulation during the electro-
myographic analysis of re-innervation. In addition, diverse
ﬁxation procedures (see Materials and Methods and Appen-
dix) may be responsible for different retention of neuro-
transmitter in the 2 templates. The TEM immunolocalization
of glutamate together with immunolocalization of VGLUT2
in presynaptic terminals of re-innervated NMJs strongly
indicate that, as in central excitatory synapses, in re-
innervated NMJs glutamate is contained in synaptic vesicles
and may be released upon stimulation in a quantal manner.
It is established that at the postsynaptic membrane of
cholinergic NMJ, the number and lifetime of AChRs are
maintained by innervation because receptors are destabilized
after denervation or block of synaptic transmission (3, 29Y32).
The clusters of AChRs never disappear (33), but a decrease
in endplate AChRs has been described in some muscle types
of young adults (34). In adult muscle ﬁbers, junctional
AChRs are composed of 4 different subunits with a stoichi-
ometry of >2A?C, whereas there is insertion of fetal F subunit
of AChRs in place of ? in either junctional or extrajunctional
regions in denervated ones (35). In denervated muscle, the
insertion of AChRs into the membrane is preceded by
upregulation of mRNA for all the subunits (35, 36). The
AChR mRNAs return to control level 2 months after de-
nervation (37, 38) or earlier if the denervated muscle is
stimulated electrically (35) or reinnervated (37). Reinnerva-
tion by cholinergic neurons restores the morphological and
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functional features of the original endplate (39). We found
that after glutamatergic reinnervation, AChR clusters persist
in muscle ﬁbers for 10 months after the surgery. This
reinnervation did not signiﬁcantly affect AChR> and AChR?
subunit expression but was associated with a stably increased
level of AChRF subunit. As occurring after cholinergic
reinnervation (40), we did not observe major morphological
alterations within the postsynaptic apparatus either by BuTx
ﬂuorescence or by TEM in the reinnervated muscle ﬁbers.
Further analysis of postsynaptic apparatus revealed a strong
positivity for the AMPA glutamate receptor GluR1 in
muscles reinnervated by glutamatergic ﬁbers, thus conﬁrming
previous biochemical and immunoﬂuorescence data (1).
Interestingly, the newly assembled glutamatergic synapses
colocalized with the cholinergic endplate areas, suggesting
that signals guiding the growth of cholinergic spinal motor
axons after nerve injury can also guide the regrowth of axons
from glutamatergic supraspinal neurons. No clustering of
glutamate receptors was detected outside the AChR-stained
NMJs. Indeed, the cholinergic postsynaptic apparatus and
AMPA receptors not only colocalized by immunoﬂuores-
cence analysis, but also coimmunoprecipitated in biochem-
ical assays. Coimmunoprecipitation assays in membrane
preparations from reinnervated muscles showed that GluR1
and GluR2 subunits interacted with both stargazin, a scaf-
folding protein of the brain postsynaptic density-regulating
AMPA receptor targeting the synaptic membrane (17, 41),
and rapsyn, the AChR-anchoring protein at the postsynaptic
apparatus of NMJs. This phenomenon may be related to a
new synthesis of GluRs in response to the glutamatergic
input or, more likely, to an increased synthesis of GluRs al-
ready expressed at the cholinergic postsynaptic membrane.
Although we were unable to detect an immunoﬂuorescence
signal for GluRs in control NMJ of rat abdominal muscles,
we cannot exclude the possibility that they are present at a
very low density.
We previously found that normal muscle ﬁbers
constitutively express mRNAs for GluR1 to 4 and, more
relevantly, that expression of GluR1 to 2 mRNAs displayed a
trend to increase in muscles reinnervated by glutamatergic
ﬁbers (1). In addition, even if at low levels, GluR1 and
GluR2 proteins, together with GLT1 and GLAST, were
detected by immunoblot analysis in specimens of control
muscles enriched with nerve terminals. Both GluR1 and
GluR2 coimmunoprecipitated with rapsyn. The hypothesis
that all the components of glutamatergic system are present in
cholinergic NMJ is also supported by a recent study showing
that GluR1 and GluR2/3 subunits along with NR1 and NR2
proteins immunolocalize at the postsynaptic membrane of
mouse quadriceps (5). Differences related to the expression
level of receptor subtypes may exist among diverse animal
species and muscle types, as suggested by the lack of NR1
protein and transcript we reported in rat abdominal muscles
(1). It has been shown that postsynaptic membranes in skele-
tal muscle ﬁbers can also express PDZ domain/containing
proteins SAP97 (5, 14, 42) and PSD-95 (14). We found that
GluR1 and GluR2 were associated with SAP97, the key
regulator of synaptic AMPA receptor trafﬁcking at the brain
postsynaptic densities. The interaction was evident in either
control or reinnervated muscles. The interaction of GluRs with
SAP97 dramatically decreased in muscles upon glutamatergic
reinnervation. This suggests that under glutamatergic input,
AMPA receptors are stably inserted at the NMJ membrane and
that SAP97 dissociates from them, as commonly occurs in
central glutamatergic synapses after AMPA receptors are stably
transferred at the postsynaptic membrane (43). In addition, no
interaction of PDS-95 with GluRs was detected; this is in line
with evidence that PSD-95 does not directly bind to AMPA
receptors and only slightly coprecipitates with GluRs (44).
These results corroborate the idea that molecules speciﬁcally
involved in intracellular transport, synaptic targeting, and
anchoring of AMPA receptors in the brain synapses are also
present at the NMJ (5, 42) and that they operate in response to
changes of AMPA receptor expression.
It has been shown recently in cultures of chick neural
tubes that selection of neurotransmitter phenotype in vertebrate
motor neurons depends on speciﬁc calcium spike activity
during embryonic neuronal development and that perturbing
these endogenous calcium oscillations may result in a shift from
acetylcholine to glutamate neurotransmitter phenotype (45).
During early embryonic development, the muscle itself
expresses mRNA and proteins of several neurotransmitter
receptors including glutamate, GABA, and glycine; these
mRNAs and proteins are subsequently downregulated to
achieve the cholinergic phenotype of the mature NMJ. In
vitro experiments show that modifying the neurotransmitter of
motor axons induces alterations in receptor expression on
muscle ﬁbers to ensure the correct transmitter-receptor match-
ing at the NMJ (46), a phenomenon with possible relevant
implications for repair in mature nervous systems (47).
Accordingly, we demonstrate that adult rat motor endplates,
committed to receive a cholinergic input and expressing high
levels of AChRs, nonetheless, retain the ability to express
glutamate receptors (1). They can shift from a cholinergic to a
glutamatergic phenotype in response to presynaptic glutama-
tergic input by increasing glutamate receptor expression to
guarantee the appropriate neurotransmitter-receptor matching.
The AChR clusters, however, remain in place and colocalize
with glutamate receptors, suggesting that signals from the
synaptic basement membrane in concert with factors released
from regrowing ﬁbers (48) can maintain AChR clusters while
driving new synaptic differentiation.
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